(2019) (44) also showed that AST treatment could attenuate inflammatory factors (TNF-α and IL-6) significantly by inhibiting MAPK/NF-κB signaling pathway in a mouse model of lipopolysaccharide (LPS)-induced sepsis and acute lung injury in vitro and in vivo. The gene discussed is NFKB1; the disease is Sepsis.